First European case of Creutzfeldt-Jakob disease with a PRNP G114V mutation.


Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
08 2019
Historique:
received: 24 06 2018
revised: 14 08 2018
accepted: 22 08 2018
pubmed: 30 9 2018
medline: 2 10 2020
entrez: 30 9 2018
Statut: ppublish

Résumé

Genetic Creutzfeldt-Jakob disease is due to mutations in the PRNP gene. Only two families with a PRNP G114V mutation have been described around the world. We report the first European case, who had no family history and initially presented with isolated deficit in hippocampus-dependent memory. Initial investigations were normal except for elevated total tau protein in the cerebrospinal fluid. He died 4 years after disease onset. This case highlights the diagnostic difficulties posed by genetic Creutzfeldt-Jakob disease, and shows that genetic analyses should be considered even in sporadic cases.

Identifiants

pubmed: 30266397
pii: S0010-9452(18)30264-8
doi: 10.1016/j.cortex.2018.08.014
pii:
doi:

Substances chimiques

PRNP protein, human 0
Prion Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

407-413

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Louis Cousyn (L)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France. Electronic address: louis.cousyn@gmail.com.

David Grabli (D)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Danielle Seilhean (D)

Department of Neuropathology, Pitié-Salpêtrière Hospital, APHP, Paris, France; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, CIC-1422, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.

Carole Azuar (C)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Camille Huiban (C)

Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, APHP, Paris, France.

Stéphane Epelbaum (S)

Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, CIC-1422, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Pitié-Salpêtrière Hospital, APHP, Paris, France.

Elodie Bouaziz-Amar (E)

Department of Biochemistry and Molecular Biology, Lariboisière Hospital, APHP, Paris, France.

Jean-Philippe Brandel (JP)

National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Damien Galanaud (D)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Aurélie Méneret (A)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France; Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, CIC-1422, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH